ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) - ANVISA Registration 80298970115

Access comprehensive regulatory information for ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80298970115 and manufactured by SHENZHEN GENIUS ELETRONICS CO LTD. The registration is held by MEDMAX COMÉRCIO DE EQUIPAMENTOS MÉDICOS E SIMILARES LTDA- ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, BIO - RAD LABORATORIES INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80298970115
Registration Details
ANVISA Registration Number: 80298970115
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

KIT DE REAGENTES DE ANTICORPO ANTIPEPTÍDEO CITRULINADO CÍCLICO (CCP)
Risk Class II

Registration Details

80298970115

25351117305201565

07760277000161

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jun 01, 2015

VIGENTE

09/18/2025 19:00:01